Viebahn U - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life.

Droege KM, Muether PS, Hermann MM, Caramoy A, Viebahn U, Kirchhof B, Fauser S. Droege KM, et al. Among authors: viebahn u. Graefes Arch Clin Exp Ophthalmol. 2013 May;251(5):1281-4. doi: 10.1007/s00417-012-2177-3. Epub 2012 Oct 20. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23086225

Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration.

Fauser S, Viebahn U, Muether PS. Fauser S, et al. Among authors: viebahn u. Acta Ophthalmol. 2015 Dec;93(8):734-8. doi: 10.1111/aos.12770. Epub 2015 May 28. Acta Ophthalmol. 2015. PMID: 26016605 Free article.

Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.

Muether PS, Hermann MM, Viebahn U, Kirchhof B, Fauser S. Muether PS, et al. Among authors: viebahn u. Ophthalmology. 2012 Oct;119(10):2082-6. doi: 10.1016/j.ophtha.2012.07.041. Epub 2012 Aug 22. Ophthalmology. 2012. PMID: 22920670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results